EFFECT OF HÆMATOCRIT ON CEREBRAL BLOOD-FLOW IN MAN
D. J. Thomas(St Thomas' Hospital), E. Zilkha(St Thomas' Hospital), N. Justin Marshall(The University of Queensland), Thomas C. Pearson(Emory Healthcare), R W Russell(St Thomas' Hospital), L. Symon(St Thomas' Hospital), G. H. du Boulay(St Thomas' Hospital), G. Wetherley‐Mein(St Thomas' Hospital)
Cited by 406
Related Papers
Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways
|Nature|1996|1.5k
4-1BB Costimulatory Signals Preferentially Induce CD8+ T Cell Proliferation and Lead to the Amplification In Vivo of Cytotoxic T Cell Responses
|The Journal of Experimental Medicine|1997|802
Rational Development of LEA29Y (belatacept), a High-Affinity Variant of CTLA4-Ig with Potent Immunosuppressive Properties
|American Journal of Transplantation|2005|714
Heterologous immunity provides a potent barrier to transplantation tolerance
|Journal of Clinical Investigation|2003|571
Phase III Study of Belatacept Versus Cyclosporine in Kidney Transplants from Extended Criteria Donors (BENEFIT‐EXT Study)
|American Journal of Transplantation|2010|566